The Rho family GTPase Rac acts as a molecular switch for signal transduction to regulate various cellular functions. Mice deficient in the hematopoietic-specific Rac2 isoform exhibit agonist-specific defects in neutrophil chemotaxis and superoxide production, despite expression of the highly homologous Rac1 isoform. To examine whether functional defects in rac2 -/-neutrophils reflect effects of an overall decrease in total cellular Rac or an isoform-specific role for Rac2, retroviral vectors were used to express exogenous Rac1 or Rac2 at levels similar to endogenous. In rac2 -/-neutrophils differentiated from transduced myeloid progenitors in vitro, increasing cellular Rac levels by expression of either exogenous Rac1 or Rac2 increased fMLP-or phorbol ester-stimulated NADPH oxidase activity. Of note, placement of an epitope tag on N-terminus of Rac1 or Rac2 blunted reconstitution of responses in rac2 -/-neutrophils.
Introduction
Neutrophils are important effector cells in the host response to bacterial and fungal pathogens and are endowed with chemotactic and microbicidal functions that are activated by signal transduction pathways downstream of receptors for inflammatory and microbial stimuli (1) . Migration from blood vessels to inflamed sites is initiated by various chemoattractants including chemokines secreted by host cells and by bacterial products such as fMLP. Superoxide produced by the neutrophil NADPH oxidase is the precursor to toxic reactive oxidants important for normal microbial killing.
Rac GTPases, members of the Rho family of small GTPases, play a central role in regulating neutrophil chemotaxis, superoxide production, and other neutrophil functions (2) . Rho GTPases act as molecular switches in signaling pathways, alternating between activated GTP-bound and inactive GDPbound states. In unstimulated cells, the GDP-bound form of Rac is bound to Rho guanine-nucleotide dissociation inhibitor (Rho-GDI) which inhibits nucleotide exchange and maintains Rac-GDP in the cytoplasm. Upon stimulation, Rac translocates to the membrane where agonist-activated guanine nucleotide exchange factors mediate the exchange of GDP for GTP, resulting in a conformational change that permits Rac binding to downstream target proteins (3) . Rac has three isoforms, the ubiquitously expressed Rac1, a hematopoietic cell-specific isoform Rac2, and Rac3 which appears to be expressed in a variety of tissues but not phagocytes (4) (5) (6) (7) (8) . The amino acid sequence of murine Rac1 is identical to human Rac1, and murine Rac2 differs by only two amino acids from human Rac2, with a conservative substitution of aspartate instead of glutamate at position 148 and a proline instead of an alanine at position 188 (5, 6) . Rac1 and Rac2 have 92% identical amino acid sequences. These two isoforms have an identical effector domain (amino acids 26 -45) , which is a critical site of interaction with both guanine nucleotide exchange factors and downstream protein targets. However, long-range effects exerted by distant isoform-divergent amino acids may alter the flexibility of the effector domain to produce different affinities of Rac1 and Rac2 for these proteins (9) . The greatest sequence divergence between Rac1 and Rac2 is in the C-terminal polybasic domain (residues 183 -188), which is adjacent to a prenylated cysteine residue that can insert into cellular membranes. Rac1 has six adjacent basic residues in the polybasic domain (KKRKRK) whereas Rac2 has only three basic residues interspersed by neutral amino acids (RQQKRA/P) (Fig. 1a) . The polybasic domain mediates differential localization of overexpressed Rac1 and Rac2 to fibroblast and epithelial cell membranes (10) , and contributes to differential interactions with at least one downstream target of activated Rac GTPases, the serine-threonine kinase PAK1 (11) . 1 Studies in murine Rac2-deficient neutrophils and neutrophils from a patient with a dominantnegative mutation in Rac2 suggest that this isoform is essential for normal neutrophil function (8, (12) (13) (14) (15) .
Although murine neutrophils have similar amounts of Rac1 and Rac2 (8) , genetic deletion of Rac2 results in severely impaired F-actin polymerization and chemotaxis in response to chemoattractants, decreased Lselectin-mediated adhesion, and reduced superoxide production in response to fMLP, phorbol ester, and IgG opsonized sheep red blood cells (8, 12, 15) . Heterozygous rac2 +/-murine neutrophils have intermediate activity between rac2 +/+ and rac2 -/-neutrophils in F-actin formation, chemotaxis, and superoxide production (8) . In human neutrophils, which have predominantly Rac2, (16) expression of a dominant-negative Rac2 results in cellular defects similar to those seen in rac2 -/-murine neutrophils (13, 14) . Although Rac1-null murine neutrophils also exhibit decreased actin cytoskeleton assembly and a modest decrease in directed migration, superoxide production is normal in contrast to Rac2-null counterparts (17) . These findings suggest that Rac1 and Rac2 play distinct roles in regulating neutrophil functions. Alternatively, the defects in Rac2-deficient neutrophils could reflect effects of an overall reduction in cellular Rac levels.
The goal of the current study was to examine whether the impaired functions of Rac2-null neutrophils result from a relative cellular deficiency of total Rac or an isoform-specific role for Rac2 that is mediated by specific sequences. Retroviral vectors were used to express exogenous Rac1 or Rac2 in rac2 -/-neutrophils at levels similar to endogenous. Increasing Rac levels by expression of either mice transplanted with transduced rac2 -/-marrow cells. This result could be recapitulated using a derivative of Rac1 in which the polybasic domain was substituted with the corresponding region from human Rac2, and conversely, expression of Rac2 chimeric for the polybasic Rac1 domain failed to rescue defects in rac2 -/-neutrophils, and resulted in disoriented motility. Thus, the polybasic domain is sufficient to confer isoform-specific Rac functions in regulating neutrophil chemotaxis and NADPH oxidase activity.
Methods

Reagents and buffers
A polyclonal Rac2 antibody was previously raised in rabbits (18) Triton X-100, 20ug/ml chymostain, 2mM PMSF, 10uM leupeptin, and 1mM 4-(2-aminoethyl benzenesulfonyl fluoride). All reagents are endotoxin-free grade. 96-well plates were from Becton Dickinson (Franklin Lakes, NJ).
Mice
Mice were maintained under specific pathogen-free conditions. Wild type (WT) mice used in this study were 8-10 week old male or female C57/Bl6J mice purchased from Jackson Laboratory Inc. Rac2 ribosome entry sequence (IRES) linked to a cDNA for the enhanced green fluorescent protein (EGFP)
instead of an antibiotic-resistance expression cassette (13) . Murine Rac1 and Rac2 cDNA's flanked by BamHI and XbaI restriction sites were originally generated using RT-PCR from RNA prepared from the RAW 264.7 mouse macrophage cell line. The flanking restriction sites were changed to XhoI, along with creation of a Kozak sequence at the initiator ATG, using oligonucleotide primers and PCR, and cloned into the XhoI site in MSCV-Pac and MIEG3 (Fig. 1b) . The murine Rac1 or Rac2 cDNA's with an Nterminal hemagglutinin (HA) or FLAG epitope tag (13, 20) , respectively, were also cloned into MSCVpac (Fig. 1b) . The human Rac1 cDNA in which the Rac2 polybasic domain was replaced with that of Rac1 (Rac1-2) and the human Rac2 cDNA in which the polybasic domain was replaced with that of Rac1 (Rac2-1) were previously described (11) . PCR was used to place EcoRI and XhoI linkers at the 5' and 3' ends, respectively, and each was subcloned into the corresponding sites in MIEG3 (Fig 1) . Details of oligonucleotide primers used for PCR amplicications are provided upon request. For all PCR-amplified cDNAs, DNA sequencing was performed to verify the fidelity of amplification. Vector plasmids were transfected using calcium phosphate into ecotropic Phoenix packaging cells (provided by Gary Nolan, Stanford University; ATCC # SD3444) and retroviral vector supernatants collected in alpha-MEM with 20% FCS.
Transduction of murine bone marrow cells with retroviral vectors for expression of Rac proteins,
Retroviral transduction of WT or rac2 -/-murine BM was generally as previously described (21), with the following modifications. Three days following injection of 150 mg/kg 5-fluorouracil (5-FU) into bone marrow (BM) donors, BM cells were taken from femurs and tibias by flushing with alpha-MEM.
The day of BM harvest was considered Day 0. BM cells were pelleted and resuspended in 10ml of red blood cell lysis solution (155mM NH 4 Cl, 10mM KHCO 3 , 100µM EDTA in H 2 O, pH7.4) in each tube, and kept at room temperature for 3min. Cells were then centrifuged and resuspended in either TD medium A (alpha-MEM with 20% serum, 100 ng/ml rat SCF, 100 ng/ml human MDGF, 100 ng/ml human G-SCF and 2% penicillin/streptomycin) or TD medium B (alpha-MEM with 20% serum, 100 
In vitro differentation of granulocytes following retroviral transduction of murine bone marrow
Neutrophils were differentiated in vitro from mock transduced or transduced BM cells by culturing in alpha-MEM with 20% serum, 50 IU/ml murine IL-3, 0.3 ng/ml (=30IU/ml) human G-SCF, and 2% penicillin/streptomycin in T75 flasks. Every other day (on day 6, 8, 10, 12, and 14 post harvest) cell number was counted, and cell density was adjusted to 5 x 10 5 cells/ml using fresh differentiation media. On day 8 through day 12, cells were selected by adding 2 µg/ml puromycin and by day 12, all mock-transduced cells exposed to puromycin had died. On day 14, cells were harvested for NADPH oxidase assays, using either transduced cells selected with puromycin or mock-transduced cells cultured in the absence of puromycin. Diff-Quik stained cytospins on day 14 showed !80 -90% mature neutrophils, with no differences seen between WT, Rac2-null, or Rac-transduced cells. The fraction of Gr-1 positive cells as analyzed by flow cytometry was also similar between between different groups.
Cell lysate was prepared on day 14-16 for SDS-PAGE and Western blotting. 
Transplantation of retrovirus-transduced murine bone marrow cells
Immunoblotting
Preparation of neutrophil lysates, SDS-PAGE, and immunoblotting were performed as described (12, 15, 22) . Briefly, neutrophils differentiated in vitro or purified from BM were treated with diisopropylphosphofluroidate prior to lysis with IP buffer (1% Triton X-100, 150 mM NaCl, 10 mM TrisCl, 1 mM EDTA, 1 mM EGTA, pH 8.0) containing 20 µg/ml chymostatin, 2 mM PMSF, 10 µM leupeptin, and 1 mM AEBSF. Following SDS-PAGE and transfer to nitrocellulose membranes, blots were sequentially probed with either an anti-Rac1 monoclonal mouse Ab, an anti-Rac2 rabbit polyclonal Ab, and an anti-p38MAPK rabbit polyclonal Ab, followed by HRP-conjugated anti-mouse or anti-rabbit IgG. Proteins were visualized using an ECL detection kit (Amersham Pharmacia Biotech). Bands were scanned and the densities were analyzed by NIH image software (http://rsb.info.nih.gov/nih-image/). Multiple exposures were analyzed to ensure that relative signal intensities measured were in the linear range.
Measurement of NADPH oxidase activity
For quantitative assays, either isoluminol chemiluminescence or a colorimetric assay based on reduction of cytochrome c was used to detect reactive oxygen species (8, 23) . Under these conditions, superoxide dismutase inhibited the chemiluminescence signal by ~97.5% and cytochrome c reduction bỹ 100%. Chemiluminescence in fMLP-stimulated cells was detected as relative luminescence units (RLU) by fast kinetic mode for 100 sec using an Lmax microplate luminometer and SoftMax Pro software (Molecular Devices, Sunnyvale, CA). The rate of cytochrome c reduction was measured as Vmax using SpectraMax340c microplate reader and the SoftMax PRO software (Molecular Devices, Sunnyvale, CA).
Chemotaxis
Neutrophil chemotaxis assays using 1 and 10 mM fMLP were performed using a modified
Boyden chamber (48-well microchemotaxis chamber, Neuro Probes, MD) and 3 mm diameter polycarbonate filter membranes as described previously (8, 15) . The number of migrated cells per high power view field (400x) were counted for a minimum of three fields per well, and an average estimation for individual sample was calculated from data of replicate wells. Values were compared relative to the number of migrated cells in the WT group.
Time-lapse video microscopy and motility analysis
Neutrophil motility in response to fMLP stimulation was recorded using a Dunn chemotaxis chamber (24) . BM neutrophils in HBSS were allowed to adhere to clean glass coverslips for 15 minutes at 37!C. The coverslips were mounted on the Dunn chamber with a gradient of 0-10 mM fMLP between the inner and outer wells of the chamber. The chamber was mounted on the microscope stage and the temperature maintained at 37!C with a stage heater (Instec Instruments, Boulder, CO). The chamber was allowed to equilibrate for 25 minutes prior to image collection to allow a stable gradient to develop.
Images were recorded at 10-second intervals on a Nikon Diaphot 300 microscope with differential interference contrast optics using a SPOT cooled CCD camera. Cell positions were tracked using the particle tracking capabilities in Metamorph 6.1 software (Universal Imaging, Brandywine, PA). Cell trajectories were analyzed using the horizon method (24, 25) , in which the position of the cell is marked once it reaches a "horizon" at 30 mm from the initial position, and used to define the trajectory of the cell relative to the orientation of the gradient. This methodology can only be applied to cell types that move a significant distance over the time period analyzed, and therefore directional data could not be obtained for
-/-cells. Directionality was evaluated relative to the null hypothesis of uniformity using the Rayleigh test (25) . In all cases over 350 cells of each type were analyzed.
Statistical analysis
The two-tailed Student's T test (either paired or unpaired, as indicated) was performed using Microsoft
Excel software (Redmond, WA). Statistical comparisons of the distribution of rates of movement between cell types were made using the Wilcoxon-Mann-Witney rank sum test with Kaleidagraph software (Synergy Software, Reading, PA). Oriana software (Kovach Computing Services, Pentraeth, Wales) was used to plot circular histograms and for statistical analysis of directional data.
Results
Expression of recombinant Rac proteins in neutrophils differentiated in vitro
In initial studies, recombinant Rac proteins were expressed in rac2 -/-neutrophils differentiated in vitro. Rac2 -/-myeloid progenitor cells were transduced with MSCV-based retroviral vectors designed to express Rac1 or Rac2. In preliminary studies using MIEG-based retroviral vectors for transduction followed by in vitro differentiation, recombinant Rac proteins were expressed at levels that were three-to six -fold greater than endogenous levels in wild-type neutrophils. 2 Therefore, subsequent in vitro studies utilized the MSCV-pac backbone, which contains a linked antibiotic resistance gene, puromycin-Nacetyl-transferase (pac) (Fig. 1b) , where exogenous Rac proteins were not overexpressed (see below).
Vectors included those in which an epitope tag was placed on the amino-terminus of Rac (an HA tag for Rac1 or a FLAG tag for Rac2) as well as those for expression of Rac1 or Rac2 without an epitope tag.
Following transduction, bone marrow cells were differentiated in vitro with G-CSF and IL-3 with or without puromycin, as described in the Methods, with !80 -90% morphologically mature neutrophils present after 12 -14 days. In the absence of selection, no differences in expansion or neutrophil differentiation were observed between WT or rac2 -/-BM that was either mock-transduced or transduced with a control vector containing only the puromycin cassette. There were also no significant differences in expansion or neutrophil differentiation between puromycin-selected WT and rac2 -/-cells transduced with the control vector containing only the puromycin cassette, or in rac2 -/-cells transduced with Raccontaining vectors.
To evaluate expression of Rac isoforms in neutrophils differentiated in vitro, we performed immunoblotting using antibodies specific for either Rac1 or Rac2 (Fig. 2a) . Recombinant Rac proteins were expressed from the MSCV-pac vectors at ! 60% of endogenous levels, based on densitometric analysis of blots from 4 independent experiments (not shown). Placement of an epitope tag retarded the migration of the recombinant Rac proteins, as expected (Fig. 2a) , but did not affect the relative level of expression. Endogenous Rac1 levels in the in vitro differentiated rac2 -/-neutrophils were not significantly increased from wild-type levels (Fig. 2a) .
NADPH oxidase activity in wild type and rac2 -/-neutrophils differentiated in vitro
Quantitative assessment of NADPH oxidase activity in neutrophils differentiated in vitro was performed using a chemiluminescence assay to detect FMLP-induced production of reactive oxidants and the cytochrome c reduction assay to measure superoxide production in cells stimulated with phorbol myristate acetate (PMA). Rac2 -/-neutrophils had substantially reduced NADPH oxidase activity compared to WT neutrophils (Fig. 2) , as previously reported for neutrophils harvested either from the bone marrow storage pool or from peritoneal exudate (8, 12, 15, 26) . For both genotypes, there was no significant difference in oxidant production between neutrophils derived from mock-transduced cells compared to puromycin-selected cells transduced with the control MSCV-pac vector (not shown).
Expression of either exogenous Rac1 or Rac2 increased NADPH oxidase activity in Rac2-null cells stimulated with either FMLP or PMA. The time course of oxidant production in representative experiments is shown in Fig. 2b and c, and aggregate data is shown in Fig. 2d and e. Of note, Rac derivatives with an epitope tag had a reduced ability to rescue NADPH oxidase activity in rac2 -/-neutrophils compared to exogenous Rac proteins lacking a tag, although both epitope-and non-epitopetagged exogenous Rac proteins were expressed at similar levels (Fig. 2a) .
Expression of Rac2 was consistently slightly more effective than exogenous Rac1 in enhancing NADPH oxidase activity in rac2 -/-neutrophils (eg . Fig 2b) , although the difference in activity between the Rac2-and Rac1-transduced groups did not reach statistical significance. Only partial reconstitution of NADPH oxidase activity was observed even in Rac2-transduced rac2 -/-neutrophils, which may reflect the fact that exogenous Rac proteins were expressed at only !60% of wild-type levels using the MSCV-pac vectors (see above Initial transplant studies using the MSCV-pac vectors (Fig. 1b) showed that recombinant Rac proteins were expressed at only !5% of wild-type levels in neutrophils produced in vivo (not shown).
Expression vectors for Rac1 and Rac2 based on the MIEG3 retrovirus (Fig. 1b) were next evaluated. 
NADPH oxidase activity of rac2 -/-neutrophils produced in vivo following transduction for expression of
Rac1 or Rac2
We examined NADPH oxidase activity in neutrophils harvested from rac2 -/-mice hematopoietically reconstituted with Rac-transduced rac2 -/-BM cells and which had 60 -92% EGFPpositive neutrophils. As shown in Fig. 3 , expression of exogenous Rac2 in rac2 -/-neutrophils restored fMLP-and PMA-stimulated activity to wild type levels. However, increased expression of Rac1 resulted in a much smaller increase in oxidant production, and the time course of fMLP-stimulated oxidant production resembled that of rac2 -/-neutrophils, lacking the rapid onset of oxidant production characteristic of fMLP-stimulated rac2 +/+ neutrophils (Fig. 3b) . Taken together, these results indicate that the Rac2 isoform is essential for normal NADPH oxidase activity in neutrophils produced in vivo, and that increased expression of Rac1 cannot compensate for its absence in rac2 -/-neutrophils.
NADPH oxidase activity in rac2 -/-neutrophils expressing Rac1 and Rac2 derivatives chimeric for the polybasic domain
Rac1 and Rac2 have the greatest sequence divergence in the polybasic domain adjacent to the prenylation site (Fig. 1a) . To determine whether this domain could mediate isoform specificity in NADPH oxidase activity in neutrophils produced in vivo, we utilized cDNAs in which the sequence encoding the polybasic domain in Rac1 was replaced with the corresponding sequence from the human Rac2 (referred to as Rac1-2), and vise versa (referred to as Rac2-1) (11) (Fig. 1a) . These cDNAs were cloned into MIEG3 retroviral vectors (Fig. 1b) , which were used to transduce rac2 -/-BM cells. Lethally irradiated rac2 -/-mice were transplanted as above with transduced cells sorted for EGFP expression.
EGFP-positive neutrophils in transplanted mice ranged from ! 75 -100%, and expression levels of Rac1-antibodies used in this study, since the Rac1-2 protein was detected by the Rac2 antibody and the Rac2-1 protein was detected by the Rac1 antibody (Fig. 4a) .
Analysis of NADPH oxidase activity in neutrophils harvested from rac2 -/-mice transplanted with Rac1-2 or Rac2-1-transduced marrow cells showed that the polybasic domain is sufficient to determine isoform specificity (Fig. 4b, c) . fMLP-or PMA-stimulated NADPH oxidase activity in Rac1-2-expressing rac2 -/-neutrophils was similar to that observed for wild-type neutrophils, including the time course of oxidant production, whereas expression of Rac2-1 produced only a very small, if any, increase in NADPH oxidase activity. Interestingly, NADPH oxidase activity in rac2 -/-neutrophils expressing exogenous Rac1 was greater than in rac2 -/-cells expressing Rac2-1 (compare Fig. 3 and Fig. 4 ).
Chemotaxis in Rac-transduced rac2 -/-neutrophils
We also analyzed chemotaxis in rac2 -/-neutrophils and Rac-transduced rac2 -/-neutrophils harvested from bone marrow. In Boyden chamber assays, expression of either the Rac2 isoform or the Rac1-2 derivative containing the polybasic domain of Rac2 restored chemotaxis of rac2 -/-neutrophils towards fMLP (Fig. 5) . However, migration of rac2 -/-neutrophils expressing either Rac2-1 or additional Rac 1 was similar to control rac2 -/-cells (Fig. 5 ).
We used time-lapse video microscopy to directly observe the motility of BM neutrophils migrating in a linear gradient of fMLP established in a Dunn (24) chemotaxis chamber. As previously described and as shown in Fig. 6, Supplementary Fig.1 , and accompanying movies in Supplementary   Figs expression of additional Rac1 only partially corrected these defects. Moreover, isoform specificity could be determined solely by sequences derived from the C-terminal polybasic domain that is adjacent to the prenylation site. A chimeric Rac1-2 protein in which the Rac1 polybasic domain was replaced with that of human Rac2 functioned in a manner similar to Rac2 in reconstituting the NADPH oxidase and chemotaxis in rac2 -/-neutrophils, whereas expression of an analogous Rac2-1 chimera did not.
A variety of molecular mechanisms could potentially account for distinct roles of Rac1 and Rac2.
Although these two isoforms have an identical amino acid sequence in the effector domain, differences in the flexibility of this loop identified in molecular modeling studies, presumably due to long-range effects of divergent residues, may result in differential binding to Rac guanine nucleotide exchange factors or downstream targets (9) . In addition, differences in a proline-rich region just N-terminal to the polybasic factor 1, to preferentially degrade Rac1 compared to other Rac isoforms (30) . However, the results of the current study indicate that the polybasic domain (residues 183 -188) is sufficient to determine the relative ability of Rac 1 and 2 to regulate superoxide production and chemotaxis in neutrophils.
The Rac polybasic domain has previously been shown to be an important determinant in a variety of cellular processes. In fibroblast and epithelial cell lines, the polybasic domain directs localization of Rac1 and Rac2 (upon their activation or when expressed in excess of RhoGDI) to either the plasma membrane or to perinuclear endosomal membranes, respectively (10) . Deletion of the polybasic domain in Rac2 impairs its biologic activities in neutophils, which in conjunction with the CAAX motif directs membrane localization (31) . The Rac1 polybasic domain contains a nuclear localization signal and Rac1 expression in the nucleus of cultured fibroblasts and epithelial cells has been reported, which may regulate Rac1 levels via proteasome-mediated degradation (10, 32, 33) . The polybasic domain can also influence interactions with proteins that regulate Rac-GTP levels or are downstream targets of Rac. For example, Rac1 binds to and activates the serine-threonine kinase PAK1 more efficiently than Rac2, with the converse observed in chimeric proteins in which the polybasic domains were swapped (11).
Phosphoinositide 5-kinase activation in epithelial cell lines is dependent on the C-terminal polybasic domain of Rac1, to which it binds more efficiently compared to the Rac2 polybasic domain (29). Coimmunoprecipitation of Rac1 with the formin/diaphanous related protein FHOS is also mediated by its polybasic domain (34) . Differences in the analogous hypervariable domain in the C-terminus of mammalian Ras isoforms have also been shown to determine specifically in localization and interaction partners (35) . Hence, the non-redundant role of Rac2 in regulating neutrophil responses could reflect polybasic domain-mediated differences in the localization of activated Rac to subcellular membrane compartments or micro domains, the relative affinities with proteins that regulate Rac activation or serve as downstream targets, or a combination of these factors.
Although expression of Rac2 or Rac1-2 was required for full reconstitution of superoxide production in rac2 -/-neutrophils in vivo, expression of exogenous Rac1 did produce small improvements.
In rac2 -/-neutrophils, Rac1 is already activated to a !three-fold greater extent compared to wild-type neutrophils (8) , and the current results suggest that increased expression of this isoform can improve phorbol ester-or fMLP-stimulated NADPH oxidase activity in rac2 -/-neutrophils. Rac1 was also recently shown to be the predominant form of Rac in human monocytes, where it was suggested to function as the main isoform for superoxide production elicited by PMA and other agonists (36) . Rac1 translocates to monocyte membranes in response to PMA, fMLP or opsonized zymosan, and co-immunoprecipitates with the p47 phox and p67 phox NADPH oxidase subunits upon opsonized zymosan stimulation (36) . Of note, murine neutrophils with a combined deficiency of both Rac1 and Rac2 have extremely low superoxide production (28) .
Also noteworthy is that expression of the Rac2-1 chimera containing the Rac1 polybasic domain did not increase NADPH oxidase activity in rac2 -/-neutrophils, in contrast to the small improvements seen with expression of exogenous Rac1. In addition, rac2 -/-neutrophils expressing Rac2-1 exhibited disoriented cell motility. The underlying basis for these observations remains to be determined.
However, the different responses when expressing exogenous Rac1 compared to Rac2-1 are not easily understood in terms of a mechanism for isoform specificity that is based solely on polybasic domaindirected localization of activated Rac.
Placement of an epitope tag on proteins is a useful strategy for distinguishing an exogenous protein from endogenous. Although not the focus of this report, it is of interest that placement of either an HA or FLAG tag on the N-terminus of Rac1 and Rac2, respectively, blunted their ability to enhance NADPH oxidase activity in rac2 -/-neutrophils. This suggests that these tags impaired Rac activation and/or downstream signaling. To our knowledge, this is the first time epitope tagging of a small GTPase has been reported to interfere with its function, although most studies typically involve overexpression in heterologous cell systems where such effects might be easily missed.
Results from this and our previous (8, 12, 15 ) studies indicate that Rac2 is a key regulator of oxidant production and motility. The assembled NADPH oxidase complex includes activated Rac, which binds to p67 phox and also likely to flavocytochrome b 558 (2, 37) . In the cell free NADPH oxidase system, recombinant prenylated Rac1 and Rac2 have equal potential for activating NADPH oxidase using purified flavocytochrome b 558 and recombinant cytosolic phox proteins (38) . Although NADPH oxidase activity elicited by opsonized zymosan is unaffected in rac2 -/-neutrophils, these cells exhibit decreased superoxide production in response to fMLP, PMA or IgG-opsonized particles (8, 12, 15) . The agonistselective defects in NADPH oxidase activity in rac2 -/-neutrophils suggest that Rac2 regulates upstream events and/or is more efficiently incorporated into the oxidase complex compared to Rac1 in response to these agonists. The first scenario is supported by the observation that Rac2-null neutrophils have other functional defects in response to agonists that are associated with reduced NADPH oxidase activity (8, 12, 15) . The parallel effects of exogenous Rac1, Rac2, and chimeric Rac proteins on chemotaxis and superoxide production by rac2 -/-neutrophils in this study is also consistent with roles in shared signaling pathways.
Our observations also support a critical role for Rac2 in cell orientation in chemotaxis. We previously showed that rac2 -/-cells, in addition to their impaired ability to move, are not polarized in the direction of the chemotactic gradient (15). We show here that Rac1-2, as well as Rac2 itself, fully rescued the ability of cells to move and, moreover, to properly orient their motility in a chemotactic gradient.
Rac2-1 cells displayed a greater defect in chemotaxis in Boyden chamber assays than the frequency and speed of migrating Rac2-1 cells might predict, but the discrepancy can easily be explained by the remarkably disoriented nature of their motility. This is consistent with the accepted critical role for Rac in chemotactic signaling pathways (39) (40) (41) , and illuminates possible isoform-specific roles in this process that have not previously been recognized. The Rac GTPases are proposed to be a component of a positive feedback loop involving the GTPase and phosphatidylinositol 3-kinase that is important for establishment of cell polarity and the maintenance of a "front-ness" signal at the leading edge (39, 40) . Although we were unable to definitively determine whether Rac1 expressing cells showed directed migration (due to their poor motility and consequent failure to reach the 30 mm horizon required for the analysis), the disoriented nature of the motile response displayed by Rac2-1 expressing cells is highly suggestive of a critical role for factors that specifically interact with the Rac2 polybasic domain in establishing cell polarity and orientation. Our results suggest the need for more work to determine interactions that specify distinct roles for Rac1 and Rac2 in regulating the cytoskeleton in hematopoietic cells.
While this manuscript was in preparation, a study by Filippi and colleagues (42) reported findings generally consistent with those described here, with a notable difference with respect to reconstitution of neutrophil motility. Similar to our results, migration of fMLP-stimulated rac2 -/-neutrophils in Boyden chambers was reconstituted by expression of Rac2. However, rescue by a Rac1-2 chimera additionally required replacement of a glycine at position 150 with aspartic acid, the residue at the corresponding position in Rac2 (42) . This contrasts with our findings, where expression of a Rac1-2 chimera was sufficient to reconstitute fMLP-stimulated chemotaxis in rac2 -/-neutrophils (Fig. 5, 6 ). However, the study by Filippi et al used the murine Rac2 polybasic domain, which differs from the human Rac2 sequence used here, in having a proline instead of an alanine at position 188 (Fig. 1a) . Other factors that may have contributed to the different results are that Filippi et al used neutrophils differentiated in vitro and exogenous Rac proteins that were HA-tagged and relatively overexpressed (42).
Filippi and coworkers also reported differences in localization of EGFP-tagged Rac proteins in murine neutrophils, which may contribute to their different functions (42) . In resting cells, EGFP-Rac1
was dispersed compared to a more central cytoplasmic and perinuclear localization for EGFP-Rac2.
Upon fMLP stimulation both forms were also detected at more peripheral locations, with Rac1 colocalizing with cortical actin and Rac2 being somewhat more interior. Moreover, in fMLP-stimulated rac2 -/-neutrophils, EGFP-Rac1 was poorly organized, suggesting that there may be crosstalk between the two Rac isoforms. Since deficient F-actin formation is a notable feature of fMLP-stimulated rac2 -/-neutrophils (15), Filippi et al proposed that Rac1 distribution may be correlated to F-actin organization and that Rac1 dysfunction in rac2 -/-neutrophils might contribute to their abnormal chemotaxis. We are currently undertaking studies to examine Rac1 and Rac2 localization in neutrophils isolated from bone marrow or peripheral blood. In preliminary studies on unstimulated murine neutrophils stained with Rac1
and Rac2 antibodies or expressing small amounts of exogenous EGFP-Rac1 or EGFP-Rac2, both isoforms were distributed diffusely in the cytosol. 3 These results are consistent with studies on resting human neutrophils, where Rac2 is cytosolic and in a complex with RhoGDI (43), but differ from the localization described by Filippi and coworkers (see above) (42) . However, Rac proteins were relatively overexpressed in the latter studies, possibly exceeding Rho-GDI binding capacity (10) , and also studied in neutrophils differentiated in vitro using relatively high concentrations of growth factors. Neither we 3 nor
Fillipi et al (42) detected a significant pool of nuclear Rac1 in neutrophils.
In conclusion, these results establish that Rac2 plays a non-overlapping role with Rac1 to regulate neutrophil chemotaxis and NADPH oxidase activity, and demonstrate that the C-terminal polybasic domain is sufficient for conferring this specificity. Future studies will address underlying mechanisms that discriminate between Rac1 and Rac2, which may include differences in subcellular targeting as well as binding to interacting regulatory or downstream target proteins. Experimental design and abbreviations are as described in Fig. 3 and 4 . Chemotaxis assays performed on freshly isolated neutrophils, using a modified Boyden chamber in response to 1mM or 10 mM fMLP as described in Methods. The ligand was loaded in the lower wells and the cells (2 x 10 5 ) were loaded in upper wells separated by a 3 mm pore size filter membrane, followed by incubation at 37!C for 45 min. 
